Global Stem Cell Therapy Market By Type (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion and Sub-Culture), Product (Adult Stem Cells, Human Embryonic Stem Cells, Induced Pluripotent Stem Cells), Applications (Musculoskeletal Disorders, Wounds, Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, Other Applications), End Users (Therapeutic Companies, Cell And Tissues Banks, Tools And Reagent Companies, Service Companies), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2027
Market Analysis and Insights: Global Stem Cell Therapy Market
Stem cell therapy market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to account to USD 18.66 billion by 2027 growing with a CAGR of 9.25% in the above-mentioned forecast period. The growing awareness to therapeutic potency of stem cells in disease organization will help in driving the growth of the stem cell therapy market.
Advanced genome-based cell analysis techniques, increase in the growth rate of public-private investments for stem cell research and identification of new stem cell lines will likely to accelerate the growth of the stem cell therapy market in the forecast period of 2020-2027. On the other hand, growing developments in infrastructure for stem cell banking will further boost various opportunities that will lead to the growth of the stem cell therapy market in the above mentioned forecast period.
Complication associated with unclear regulatory guidelines for product development & commercialization and preservation of stem cell and difficulty while collecting adult stem cell or somatic stem cells will likely to hamper the growth of the stem cell therapy market in the above mentioned forecast period.
The technical limitations related to production scale-up are going to pose challenge for the stem cell therapy market.
This stem cell therapy market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographical expansions, technological innovations in the market. To gain more info on stem cell therapy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Stem Cell Therapy Market Scope and Market Size
Stem cell therapy market is segmented on the basis of type, technology, product, applications and end users. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, the stem cell therapy market is segmented into allogeneic stem cell therapy and autologous stem cell therapy. The allogeneic stem cell therapy is further sub-segmented into musculoskeletal disorders, wounds and injuries, surgeries, acute graft-versus-host disease (AGVHD) and other. The autologous stem cell therapy is further sub segmented into wounds and injuries, cardiovascular diseases, gastrointestinal diseases and others.
- On the basis of technology, the stem cell therapy market is segmented into cell acquisition, cell production, cryopreservation and expansion and sub-culture. The cell acquisition is further sub segmented into bone marrow harvest, umbilical blood cord and apheresis. The cell production is further sub segmented into therapeutic cloning, In-vitro fertilization, cell culture and isolation.
- On the basis of product, the stem cell therapy market is segmented into adult stem cells, human embryonic stem cells and induced pluripotent stem cells
- Based on application, the stem cell therapy market is segmented into musculoskeletal disorders, wounds, injuries, cardiovascular diseases, surgeries, gastrointestinal diseases and other applications
- Stem cell therapy market has also been segmented based on the end users into therapeutic companies, cell and tissues banks, tools and reagent companies and service companies.
Stem Cell Therapy Market Country Level Analysis
Stem cell therapy market is analysed and market size insights and trends are provided by country, source, type, application and end users as referenced above.
The countries covered in the Stem Cell Therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the stem cell therapy market due to rising public awareness related to the therapeutic potency of stem cells in disease therapy, growing number of clinical trials that aim to evaluate the therapeutic potential of stem cell-based products, increasing public-private funding & research grants for developing safe and effective stem cell therapy products and growing patient base for target diseases, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2020 to 2027 due to strong product pipelines in regenerative therapies and large patient population.
The country section of the stem cell therapy market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Stem Cell Therapy Market Share Analysis
Stem cell therapy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to stem cell therapy market.
The major players covered in the stem cell therapy market report are Osiris Therapeutics, Inc., MEDIPOST Co., Ltd., Anterogen Co., Ltd., Pharmicell Co., Ltd., STEMCELL Technologies Inc., Astellas Pharma Inc., Cellular Engineering Technologies Inc., BioTime Inc., Takara Bio Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics Inc., Caladrius Biosciences, Inc., Athersys., Cytori Therapeutics, Inc., Fate Therapeutics Inc., Pluristem Therapeutics Inc., Thermo Fisher Scientific., Vericel Corporation., ViaCyte, Inc, AbbVie, Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, Aastrom Biosciences, Inc., Advanced Cell Technology, Cryo Cell International, Geron Corporation and Invitrogen among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available: Global Stem Cell Therapy Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.